CYP 870 (Carbinoxamine 4 mg)
Pill imprint CYP 870 has been identified as Carbinoxamine maleate 4 mg.
Carbinoxamine is used in the treatment of allergic rhinitis; allergic urticaria; dermatographism; conjunctivitis, allergic; allergic reactions (and more), and belongs to the drug class antihistamines. Risk cannot be ruled out during pregnancy. Carbinoxamine 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- CYP 870
- Strength:
- 4 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antihistamines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Cypress Pharmaceutical Inc
- National Drug Code (NDC):
- 60258-0870
- Inactive Ingredients:
- lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
More about carbinoxamine
Consumer resources
- Carbinoxamine maleate
- Carbinoxamine maleate extended-release capsules
- Carbinoxamine maleate extended-release suspension
- Carbinoxamine maleate liquid
- Carbinoxamine maleate/tannate
- More (2) »
- Other brands: Palgic, Karbinal ER, Carboxine, Arbinoxa, More (5) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
